semaglutide yog dab tsi

S20

Semaglutide yog dab tsi?

Semaglutide yog ib qho hluavtaws analog ntawm tib neeg incretin hormone GLP-1. Endogenous GLP-1 raug tso tawm los ntawm L-cov cell ntawm txoj hnyuv hauv cov lus teb rau kev noj zaub mov thiab ua rau ntau lub qabzib- ua haujlwm raws li: nws txhawb nqa insulin secretion los ntawm pancreatic beta-cells, inhibits glucagon tso tawm ntawm alpha-hlwb, slows gastric khoob, thiab txhawb nqa. satiety nyob rau hauv lub central paj hlwb. Txawm li cas los xij, haiv neeg GLP-1 muaj ib nrab ntawm lub neej luv luv ntawm tsuas yog 1-2 feeb vim kev puas tsuaj sai los ntawm enzyme dipeptidyl peptidase-4 (DPP-4).

Semaglutide yog tsim los rau kev ua haujlwm ntev. Nws cov qauv nta ib qho kev hloov kho uas ua rau nws txoj kev sib raug zoo rau albumin, txo nws lub raum tshem tawm thiab ua rau nws tiv taus DPP-4 degradation. Qhov no ua rau ib nrab - lub neej ntawm kwv yees li ib lub lis piam, tso cai rau kev tswj hwm subcutaneous ib zaug ib lim tiam.

Kev ua tau zoo ntawm Semaglutide:

Kev kho mob ua tau zoo ntawm semaglutide yog qhov zoo- tsim los ntawm loj - nplai, randomized tswj kev sim.

1.Glycemic Control nyob rau hauv Hom 2 Ntshav Qab Zib: Hauv cov neeg mob uas muaj ntshav qab zib hom 2, semaglutide ua kom pom muaj zog HbA1c- txo qis, feem ntau yog li ntawm 1.5% mus rau 2.0%. Nws cov piam thaj-raws li cov txheej txheem ntawm kev ua haujlwm ua rau muaj kev pheej hmoo tsawg ntawm hypoglycemia thaum siv yam tsis muaj insulin lossis insulin secretagogues. Lub plab zom mov qeeb kuj tseem pab txo qis cov piam thaj tom qab noj mov.

2.Weight Management: Semaglutide cov teebmeem ntawm kev poob phaus yog qhov tob. Los ntawm kev ua ntawm cov chaw qab los noj mov hauv lub hlwb (tshwj xeeb yog hypothalamus), nws txo qis kev tshaib kev nqhis thiab calorie ntau ntau. Kev sim tshuaj kho mob rau kev tswj qhov hnyav hnyav tau pom qhov hnyav nruab nrab ntawm 15-20% ntawm lub cev hnyav tshaj 68 lub lis piam, tsim kom nws ua ib qho tshuaj tiv thaiv kev rog tshaj plaws muaj.

3.Cardiovascular Benefits: Semaglutide tau pom cov txiaj ntsig tseem ceeb ntawm cov hlab plawv (CV). Lub SUSTAIN-6 thiab PIONEER-6 qhov kev sim tau pom tias semaglutide txo qhov kev pheej hmoo ntawm cov teeb meem mob plawv loj (MACE)-ib qho kev sib xyaw ntawm CV tuag, tsis yog-fatal myocardial infarction, thiab tsis yog mob stroke-hauv cov neeg mob uas muaj ntshav qab zib hom 2. kab mob plawv lossis muaj kev pheej hmoo siab CV.

4. Cov txiaj ntsig ntawm lub raum: Cov pov thawj tshwm sim los ntawm kev tshaj tawm -hoc kev tshuaj xyuas thiab kev sim siab zoo li FLOW qhia tias semaglutide kuj tseem tuaj yeem muaj cov teebmeem renoprotective, ua rau qeeb ntawm kev mob ntshav qab zib hauv lub raum los ntawm kev txo qis albuminuria thiab ncua kev poob qis hauv kwv yees glomerular filtration rate (eGFR).

weight loss

Leej twg yog tus neeg sib tw tsim nyog rau Semaglutide?

Qhov tsim nyog rau semaglutide nyob ntawm qhov qhia tshwj xeeb thiab tus neeg mob profile.

1.Rau hom 2 mob ntshav qab zib mellitus: Nws yog qhia raws li kev noj haus thiab kev tawm dag zog kom txhim kho glycemic tswj rau cov neeg laus uas muaj ntshav qab zib hom 2. Nws yog tshwj xeeb tshaj yog haum rau:

Cov neeg mob uas tsis tau ua tiav cov hom phiaj glycemic nrog metformin thiab / lossis lwm yam tshuaj tiv thaiv qhov ncauj.
Cov uas yuav tau txais txiaj ntsig los ntawm kev poob phaus.
Cov neeg mob uas tsim cov kab mob plawv, qhov twg nws cov teebmeem cardioprotective yog qhov zoo dua.

2.For Chronic Weight Management: Nws tau pom zoo rau kev tswj qhov hnyav hauv cov neeg laus nrog:

Lub cev qhov hnyav (BMI) ntawm 30 kg / m² lossis ntau dua (kev rog), lossis
BMI ntawm 27 kg/m² los yog ntau dua (hnyav) nyob rau hauv muaj tsawg kawg yog ib qhov hnyav -txog comorbidity (xws li, kub siab, ntshav qab zib hom 2, dyslipidemia).

Package